Human peptidylarginine deiminase type II: molecular cloning, gene organization, and expression in human skin.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 12392711)

Published in Arch Biochem Biophys on November 01, 2002

Authors

Akihito Ishigami1, Takako Ohsawa, Hiroaki Asaga, Kyoichi Akiyama, Masashi Kuramoto, Naoki Maruyama

Author Affiliations

1: Department of Molecular Pathology, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo, Japan. ishigami@tmig.or.jp

Articles citing this

Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis (2004) 2.82

A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population. Ann Rheum Dis (2004) 1.36

Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation. J Exp Med (2008) 1.34

Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis? Arthritis Res Ther (2010) 1.03

Chemical biology of protein arginine modifications in epigenetic regulation. Chem Rev (2015) 0.99

Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis. Am J Pathol (2008) 0.97

Local administration of glucocorticoids decreases synovial citrullination in rheumatoid arthritis. Arthritis Res Ther (2012) 0.97

Functional role of dimerization of human peptidylarginine deiminase 4 (PAD4). PLoS One (2011) 0.91

Discovery of peptidylarginine deiminase-4 substrates by protein array: antagonistic citrullination and methylation of human ribosomal protein S2. Mol Biosyst (2011) 0.88

Citrullination alters immunomodulatory function of LL-37 essential for prevention of endotoxin-induced sepsis. J Immunol (2014) 0.86

PADI4 and tumourigenesis. Cancer Cell Int (2010) 0.85

NF-Y and Sp1/Sp3 are involved in the transcriptional regulation of the peptidylarginine deiminase type III gene (PADI3) in human keratinocytes. Biochem J (2006) 0.82

Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation. Curr Drug Targets (2015) 0.79

A rigorous method for multigenic families' functional annotation: the peptidyl arginine deiminase (PADs) proteins family example. BMC Genomics (2005) 0.79

A Critical Reappraisal of Neutrophil Extracellular Traps and NETosis Mimics Based on Differential Requirements for Protein Citrullination. Front Immunol (2016) 0.78

Functional roles of the non-catalytic calcium-binding sites in the N-terminal domain of human peptidylarginine deiminase 4. PLoS One (2013) 0.78

Molecular Interplay between the Dimer Interface and the Substrate-Binding Site of Human Peptidylarginine Deiminase 4. Sci Rep (2017) 0.75

Lowering relative humidity level increases epidermal protein deimination and drives human filaggrin breakdown. J Dermatol Sci (2017) 0.75

Downregulation of lizard immuno-genes in the regenerating tail and myogenes in the scarring limb suggests that tail regeneration occurs in an immuno-privileged organ. Protoplasma (2017) 0.75

Articles by these authors

Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Crit Care Med (2006) 2.87

Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J Neurosci Res (2005) 1.57

Senescence marker protein-30/gluconolactonase deletion worsens glucose tolerance through impairment of acute insulin secretion. Endocrinology (2009) 1.55

Antioxidant, EUK-8, prevents murine dilated cardiomyopathy. Circ J (2009) 1.52

Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc Natl Acad Sci U S A (2006) 1.37

Senescence marker protein-30 knockout mouse liver is highly susceptible to tumor necrosis factor-alpha- and Fas-mediated apoptosis. Am J Pathol (2002) 1.30

Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice. Biochem Biophys Res Commun (2008) 1.29

Induction of myasthenia by immunization against muscle-specific kinase. J Clin Invest (2006) 1.13

SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life span. Biochem Biophys Res Commun (2004) 1.12

SMP30 deficiency causes increased oxidative stress in brain. Mech Ageing Dev (2006) 1.01

Senescence marker protein-30 is a unique enzyme that hydrolyzes diisopropyl phosphorofluoridate in the liver. FEBS Lett (2004) 0.99

Modulation of gene expression of SMP-30 by LPS and calorie restriction during aging process. Exp Gerontol (2004) 0.97

Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis. Am J Pathol (2008) 0.97

Ascorbic acid depletion enhances expression of the sodium-dependent vitamin C transporters, SVCT1 and SVCT2, and uptake of ascorbic acid in livers of SMP30/GNL knockout mice. Arch Biochem Biophys (2010) 0.96

Complete lack of vitamin C intake generates pulmonary emphysema in senescence marker protein-30 knockout mice. Am J Physiol Lung Cell Mol Physiol (2010) 0.95

Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis. Am J Pathol (2011) 0.92

Role of DNA methylation in transcription of human endogenous retrovirus in the pathogenesis of systemic lupus erythematosus. J Rheumatol (2002) 0.91

Mitochondrial reactive oxygen species generation by the SDHC V69E mutation causes low birth weight and neonatal growth retardation. Mitochondrion (2010) 0.91

Vitamin C depletion increases superoxide generation in brains of SMP30/GNL knockout mice. Biochem Biophys Res Commun (2008) 0.91

Time course of vitamin C distribution and absorption after oral administration in SMP30/GNL knockout mice. Nutrition (2010) 0.91

Involvement of peptidylarginine deiminase-mediated post-translational citrullination in pathogenesis of sporadic Creutzfeldt-Jakob disease. Acta Neuropathol (2009) 0.90

A selective NFkappaB inhibitor, DHMEQ, reduced atherosclerosis in ApoE-deficient mice. J Atheroscler Thromb (2006) 0.90

Senescence marker protein-30 regulates Akt activity and contributes to cell survival in Hep G2 cells. Biochem Biophys Res Commun (2004) 0.89

Vitamin C prevents cigarette smoke-induced pulmonary emphysema in mice and provides pulmonary restoration. Am J Respir Cell Mol Biol (2014) 0.89

Senescence marker protein-30 (SMP30) induces formation of microvilli and bile canaliculi in Hep G2 cells. Cell Tissue Res (2005) 0.89

Increased and type II-specific expression of peptidylarginine deiminase in activated microglia but not hyperplastic astrocytes following kainic acid-evoked neurodegeneration in the rat brain. Neurosci Lett (2002) 0.87

Molecular characterization of senescence marker protein-30 gene promoter: identification of repressor elements and functional nuclear factor binding sites. BMC Mol Biol (2008) 0.87

Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease. J Gastroenterol (2009) 0.86

Senescence marker protein-30 knockout mouse as a novel murine model of senile lung. Pathol Int (2004) 0.86

Over-expression of Senescence Marker Protein-30 decreases reactive oxygen species in human hepatic carcinoma Hep G2 cells. Biol Pharm Bull (2009) 0.84

MURC/Cavin-4 facilitates recruitment of ERK to caveolae and concentric cardiac hypertrophy induced by α1-adrenergic receptors. Proc Natl Acad Sci U S A (2014) 0.84

Importance of research on peptidylarginine deiminase and citrullinated proteins in age-related disease. Geriatr Gerontol Int (2010) 0.84

Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis. J Neuroimmunol (2012) 0.83

Hypoglycemia due to ectopic secretion of insulin-like growth factor-I in a patient with an isolated sarcoidosis of the spleen. Endocr J (2010) 0.83

Myasthenia gravis experimentally induced with muscle-specific kinase. Ann N Y Acad Sci (2007) 0.83

Senescence marker protein-30 knockout mouse as an aging model. Ann N Y Acad Sci (2004) 0.83

Control of cerebral cortical blood flow by stimulation of basal forebrain cholinergic areas in mice. J Physiol Sci (2011) 0.82

3,4-Diaminopyridine improves neuromuscular transmission in a MuSK antibody-induced mouse model of myasthenia gravis. J Neuroimmunol (2012) 0.82

Subcellular localization of peptidylarginine deiminase 2 and citrullinated proteins in brains of scrapie-infected mice: nuclear localization of PAD2 and membrane fraction-enriched citrullinated proteins. J Neuropathol Exp Neurol (2011) 0.82

Elevated levels of 4-hydroxynonenal-histidine Michael adduct in the hippocampi of patients with Alzheimer's disease. Biomed Res (2009) 0.82

Pancreatic insulin release in vitamin C-deficient senescence marker protein-30/gluconolactonase knockout mice. J Clin Biochem Nutr (2011) 0.82

Vitamin C is not essential for carnitine biosynthesis in vivo: verification in vitamin C-depleted senescence marker protein-30/gluconolactonase knockout mice. Biol Pharm Bull (2008) 0.82

Ascorbic acid enhances the expression of type 1 and type 4 collagen and SVCT2 in cultured human skin fibroblasts. Biochem Biophys Res Commun (2012) 0.81

Effects of ascorbic acid deficiency on protein and lipid oxidation in livers from SMP30/GNL knockout mice. J Nutr Sci Vitaminol (Tokyo) (2013) 0.81

Bioavailability of vitamin C from mashed potatoes and potato chips after oral administration in healthy Japanese men. Br J Nutr (2011) 0.80

Effect of ascorbic acid deficiency on catecholamine synthesis in adrenal glands of SMP30/GNL knockout mice. Eur J Nutr (2013) 0.80

Effect of vitamin C depletion on UVR-B induced cataract in SMP30/GNL knockout mice. Exp Eye Res (2011) 0.80

Myositis ossificans traumatica of the masticatory muscles. J Craniofac Surg (2012) 0.80

Developmental and age-related changes of peptidylarginine deiminase 2 in the mouse brain. J Neurosci Res (2010) 0.79

Phosphoproteomic profiling of human SH-SY5Y neuroblastoma cells during response to 6-hydroxydopamine-induced oxidative stress. Biochim Biophys Acta (2006) 0.79

Exome sequencing of senescence-accelerated mice (SAM) reveals deleterious mutations in degenerative disease-causing genes. BMC Genomics (2013) 0.79

Ascorbic acid levels in various tissues, plasma and urine of mice during aging. J Nutr Sci Vitaminol (Tokyo) (2012) 0.79

Peptidylarginine deiminase and protein citrullination in prion diseases: strong evidence of neurodegeneration. Prion (2012) 0.79

Absorption and excretion of ascorbic acid alone and in acerola (Malpighia emarginata) juice: comparison in healthy Japanese subjects. Biol Pharm Bull (2011) 0.79

Peptidylarginine deiminase modulates the physiological roles of enolase via citrullination: links between altered multifunction of enolase and neurodegenerative diseases. Biochem J (2012) 0.79

A novel animal model of thymic tumour: development of epithelial thymoma in transgenic rats carrying human T lymphocyte virus type I pX gene. Int J Exp Pathol (2002) 0.79

Anti-inflammatory activity of SMP30 modulates NF-κB through protein tyrosine kinase/phosphatase balance. J Mol Med (Berl) (2014) 0.79

Immune abnormalities induced by human endogenous retroviral peptides: with reference to the pathogenesis of systemic lupus erythematosus. J Clin Immunol (2003) 0.79

17β-Estradiol attenuates saturated fatty acid diet-induced liver injury in ovariectomized mice by up-regulating hepatic senescence marker protein-30. Biochem Biophys Res Commun (2011) 0.78

Senescence marker protein-30 as a novel antiaging molecule. Ann N Y Acad Sci (2004) 0.78

Citrullination preferentially proceeds in glomerular Bowman's capsule and increases in obstructive nephropathy. Kidney Int (2005) 0.78

Nuclear localization of senescence marker protein-30, SMP30, in cultured mouse hepatocytes and its similarity to RNA polymerase. Biosci Biotechnol Biochem (2003) 0.78

Lepr(db/db) Mice with senescence marker protein-30 knockout (Lepr(db/db)Smp30(Y/-)) exhibit increases in small dense-LDL and severe fatty liver despite being fed a standard diet. PLoS One (2013) 0.78

Pathological similarities between low birth weight-related nephropathy and nephropathy associated with mitochondrial cytopathy. Diagn Pathol (2014) 0.78

A significant relationship between plasma vitamin C concentration and physical performance among Japanese elderly women. J Gerontol A Biol Sci Med Sci (2011) 0.77

Helix-sense-selective polymerization of phenylacetylene having two hydroxy groups using a chiral catalytic system. J Am Chem Soc (2003) 0.77

Senescence marker protein 30 is up-regulated in kainate-induced hippocampal damage through ERK-mediated astrocytosis. J Neurosci Res (2009) 0.77

Uric acid levels in tissues and plasma of mice during aging. Biol Pharm Bull (2012) 0.77

Two novel sandwich ELISAs identify PAD4 levels and PAD4 autoantibodies in patients with rheumatoid arthritis. Mod Rheumatol (2012) 0.77

Age-related changes of dopamine, noradrenaline and adrenaline in adrenal glands of mice. Geriatr Gerontol Int (2012) 0.76

Ascorbic acid deficiency leads to epidermal atrophy and UVB-induced skin pigmentation in SMP30/GNL knockout hairless mice. J Invest Dermatol (2012) 0.76

Semisynthesis of human ghrelin: condensation of a Boc-protected recombinant peptide with a synthetic O-acylated fragment. Biopolymers (2005) 0.76

Function of adrenomedullin in inflammatory response of liver against LPS-induced endotoxemia. APMIS (2012) 0.76

Ascorbic acid prevents protein oxidation in livers of senescence marker protein-30/gluconolactonase knockout mice. Geriatr Gerontol Int (2013) 0.76

Potato chip intake increases ascorbic acid levels and decreases reactive oxygen species in SMP30/GNL knockout mouse tissues. J Agric Food Chem (2014) 0.76

Structural basis of the γ-lactone-ring formation in ascorbic acid biosynthesis by the senescence marker protein-30/gluconolactonase. PLoS One (2013) 0.76

Insufficient ascorbic acid intake during gestation induces abnormal cardiac dilation in fetal and neonatal SMP30/GNL knockout mice. Pediatr Res (2013) 0.75

In vitro effects of Habu snake venom on cultured mesangial cells. Nephron (2002) 0.75

Primary percutaneous coronary intervention and intravascular ultrasound imaging for coronary thrombosis after cisplatin-based chemotherapy. Heart Vessels (2012) 0.75

[Aspects from the biomedical gerontology]. Nihon Ronen Igakkai Zasshi (2008) 0.75

Transient brain hyperperfusion detected with I-123 IMP SPECT in a patient with neuropsychiatric systemic lupus erythematosus. Clin Nucl Med (2009) 0.75

The redox-sensitive DNA binding sites responsible for age-related downregulation of SMP30 by ERK pathway and reversal by calorie restriction. Antioxid Redox Signal (2006) 0.75

Establishment and characterization of hepatocytes from an Immortomouse/SMP30/GNL knockout mouse hybrid lacking vitamin C to study vitamin C transport. J Biochem (2011) 0.75

[A case of crescentic glomerulonephritis developed under oral anastrozole treatment]. Gan To Kagaku Ryoho (2013) 0.75

Recent advances in gerontology reveal that some of those old stories are the basis for today's scientific facts. Preface. Geriatr Gerontol Int (2010) 0.75

[In Process Citation]. Nihon Ronen Igakkai Zasshi (2015) 0.75

[Localization of senescence marker protein-30 (SMP30) in the mouse submandibular gland and histological findings in the SMP30 knock-out mouse]. Nihon Jibiinkoka Gakkai Kaiho (2002) 0.75

[Pathophysiological significances of citrullinated proteins in geriatric diseases]. Nihon Ronen Igakkai Zasshi (2005) 0.75

Senescence marker protein-30/gluconolactonase expression in the mouse ovary during gestation. Biol Pharm Bull (2013) 0.75

[Clinical characteristics of patients diagnosed as high cardiac event probability by "Heart Risk View"]. Kaku Igaku (2011) 0.75

Quantitative analysis of mRNA in human temporal bones. Acta Otolaryngol (2007) 0.75

Development of a new distyrylbenzene-derivative amyloid-β-aggregation and fibril formation inhibitor. Chem Pharm Bull (Tokyo) (2012) 0.75